Primary sterile necrotic cells fail to cross-prime CD8+ T cells
暂无分享,去创建一个
M. Manns | T. Greten | M. Heimesaat | F. Korangy | C. Kirschning | Jaba Gamrekelashvili | Lars A. Ormandy
[1] B. Thompson,et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. , 2012, Immunity.
[2] F. Di Virgilio,et al. Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.
[3] Masaaki Komatsu,et al. Autophagy: Renovation of Cells and Tissues , 2011, Cell.
[4] L. Zitvogel,et al. How to improve the immunogenicity of chemotherapy and radiotherapy , 2011, Cancer and Metastasis Reviews.
[5] C. Caux,et al. CpG Promotes Cross-Presentation of Dead Cell-Associated Antigens by Pre-CD8α+ Dendritic Cells , 2011, The Journal of Immunology.
[6] J. Tschopp,et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.
[7] O. Kepp,et al. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells , 2009, Cell Death and Differentiation.
[8] Anna M. Keller,et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity , 2009, Nature.
[9] J. Yewdell,et al. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. , 2008, Immunity.
[10] T. Hartung,et al. Cellular Recognition of Trimyristoylated Peptide or Enterobacterial Lipopolysaccharide via Both TLR2 and TLR4* , 2007, Journal of Biological Chemistry.
[11] M. Manns,et al. Necrotic Tumor Cell Death In Vivo Impairs Tumor-Specific Immune Responses1 , 2007, The Journal of Immunology.
[12] L. Zitvogel,et al. Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.
[13] C. Figdor,et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity , 2006, British Journal of Cancer.
[14] C. Figdor,et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. , 2006, Cancer research.
[15] B. Beutler,et al. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. , 2006, Immunity.
[16] L. Zitvogel,et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death , 2005, The Journal of experimental medicine.
[17] G. Prestwich,et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.
[18] J. Yewdell. The seven dirty little secrets of major histocompatibility complex class I antigen processing. , 2005, Immunological reviews.
[19] D. Tscharke,et al. CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates , 2004, Science.
[20] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[21] James E. Evans,et al. Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.
[22] M. Leist,et al. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells , 2003, Cell Death and Differentiation.
[23] J. Frelinger,et al. Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells1 , 2003, The Journal of Immunology.
[24] Jongdae Lee,et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Manns,et al. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo , 2003, International journal of cancer.
[26] R. Steinman,et al. Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ , 2002, The Journal of experimental medicine.
[27] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[28] Carsten J. Kirschning,et al. The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 Activates Dendritic Cells via the Toll-like Receptor 2/4 Pathway* , 2002, The Journal of Biological Chemistry.
[29] F. Westwood,et al. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] Carsten J. Kirschning,et al. HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway* , 2002, The Journal of Biological Chemistry.
[31] G. Kroemer,et al. Genetic analysis of the mammalian cell death machinery. , 2002, Trends in genetics : TIG.
[32] N. Bhardwaj,et al. Primary Tumor Tissue Lysates Are Enriched in Heat Shock Proteins and Induce the Maturation of Human Dendritic Cells1 , 2001, The Journal of Immunology.
[33] Cevayir Coban,et al. Genomic DNA Released by Dying Cells Induces the Maturation of APCs1 2 , 2001, The Journal of Immunology.
[34] C. Bruyns,et al. The P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells1 , 2001, The Journal of Immunology.
[35] C. Kurts,et al. Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo1 , 2001, The Journal of Immunology.
[36] W. Heath,et al. Cross-presentation, dendritic cells, tolerance and immunity. , 2001, Annual review of immunology.
[37] K. Rock,et al. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[39] T. Mak,et al. Executionary pathway for apoptosis: lessons from mutant mice , 2000, Cell Research.
[40] P. Srivastava,et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. , 2000, International immunology.
[41] H. Rammensee,et al. The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor , 2000, European journal of immunology.
[42] C. Klein,et al. Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines , 2000, The Journal of experimental medicine.
[43] C. Kurts,et al. Characterization of the ovalbumin‐specific TCR transgenic line OT‐I: MHC elements for positive and negative selection , 2000, Immunology and cell biology.
[44] Nina Bhardwaj,et al. Consequences of cell death: exposure to necrotic tumor cells , 2000 .
[45] A. Lanzavecchia,et al. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells , 2000, European journal of immunology.
[46] Stefania Gallucci,et al. Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.
[47] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[48] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[49] S Oehen,et al. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.
[50] C. Kurts,et al. Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction , 2022 .
[51] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[52] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[53] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.
[54] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[55] S. Silagi. CONTROL OF PIGMENT PRODUCTION IN MOUSE MELANOMA CELLS IN VITRO , 1969, The Journal of cell biology.